Fischer Medical Ventures' Q1 FY 2026-27 Quarterly Results
- 16 Aug 2026
Result Summary
- Fischer Medical Ventures Ltd reported a 15.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 169.8%.
- Its expenses for the quarter were down by 25.4% QoQ and up 266.5% YoY.
- The net profit decreased 153.2% QoQ and decreased 24.4% YoY.
- The earnings per share (EPS) of Fischer Medical Ventures Ltd stood at 0.05 during Q1 FY 2026-27.
Financial Statments for Q1 FY 2026-27
(₹ crores) | Q1FY27 | Q4FY26 | Q1FY26 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 83.40 | 99.01 | 30.91 | -15.8% | 169.8% |
Total Expenses | 75.57 | 101.27 | 20.62 | -25.4% | 266.5% |
Profit Before Tax | 7.83 | -2.25 | 10.17 | -448.0% | -23.0% |
Tax | 4.04 | 4.86 | 5.17 | -16.9% | -21.9% |
Profit After Tax | 3.79 | -7.12 | 5.01 | -153.2% | -24.4% |
Earnings Per Share | 0.05 | -0.10 | 0.09 | -150.0% | -44.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Fischer Medical Ventures Ltd is a company presumably operating in the healthcare or medical sector, as suggested by its name. However, specific information about its main products or services, industry, or recent major developments is not available from the provided data. For a comprehensive understanding of the company's operations and strategic direction, additional research outside the provided dataset would be required.
Revenue
In the first quarter of FY27, Fischer Medical Ventures Ltd reported a total income of ₹83.40 crores. This represents a decrease of 15.8% compared to the previous quarter (Q4FY26), which had a total income of ₹99.01 crores. However, on a year-over-year basis, there is a significant increase of 169.8% from Q1FY26, where the total income was ₹30.91 crores. This substantial year-over-year growth indicates a considerable expansion in revenue compared to the same period last year.
Profitability
The company reported a profit before tax of ₹7.83 crores in Q1FY27. This marks an improvement from the previous quarter (Q4FY26), where the company had a loss before tax of ₹2.25 crores. Compared to the first quarter of the previous fiscal year (Q1FY26), there is a 23.0% decline from a profit before tax of ₹10.17 crores. After accounting for tax, the profit after tax for Q1FY27 was ₹3.79 crores, showing a recovery from a loss after tax of ₹7.12 crores in the previous quarter. Year-over-year, the profit after tax decreased by 24.4% from ₹5.01 crores in Q1FY26.
Operating Metrics
The total expenses for Q1FY27 were ₹75.57 crores, which shows a decrease of 25.4% from the previous quarter’s expenses of ₹101.27 crores. However, there is a significant increase of 266.5% in total expenses compared to ₹20.62 crores in Q1FY26. The earnings per share (EPS) for Q1FY27 were ₹0.05, which represents a recovery from a negative EPS of ₹-0.10 in Q4FY26. Compared to Q1FY26, where the EPS was ₹0.09, there is a decrease of 44.4%. The tax expense for Q1FY27 was ₹4.04 crores, which is lower than both the previous quarter’s tax of ₹4.86 crores and the tax expense of ₹5.17 crores in Q1FY26. The financial data presents a varied picture with notable changes in income, expenses, and profitability metrics.
FAQs
Fischer Medical Ventures Ltd announced its Q1 FY 2026-27 results on 16 August, 2026.
Fischer Medical Ventures Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Fischer Medical Ventures Ltd Q1 FY 2026-27 results include:
- Revenue: ₹83.40 crore
- Net Profit: ₹3.79 crore
- EBITDA: ₹12.74 crore
- Year-over-Year Growth: 169.8%
- Quarter-over-Quarter Growth: -15.8%
Fischer Medical Ventures Ltd reported a net loss of ₹3.79 crore in Q1 FY 2026-27, reflecting a -24.4% year-over-year growth.
Fischer Medical Ventures Ltd posted a revenue of ₹83.40 crore in Q1 FY 2026-27.